Core Viewpoint - Morgan Stanley updates the risk-return forecast for Angelalign, raising revenue projections for 2025, 2026, and 2027 by 6.9%, 9.3%, and 10.6% respectively to align with management's target of 250,000 cases in the Chinese market and 240,000 to 250,000 cases in overseas markets [1] Revenue Projections - Revenue forecasts for 2025, 2026, and 2027 have been increased by 6.9%, 9.3%, and 10.6% respectively [1] Profit Forecasts - Net profit estimates for 2026 and 2027 have been raised by 6.3% and 11% respectively, indicating faster-than-expected expansion in overseas markets [1] Target Price Adjustment - The target price based on discounted cash flow (DCF) has been raised from HKD 65 to HKD 74, maintaining a rating of "in line with the market" [1]
大行评级｜大摩：上调时代天使目标价至74港元 上调2025至27年收入预测